Esomeprazole: all 260 studies that test it
Page 3 of 3. Open to participants first (16), then studies with results posted, then the rest; newest registration first within each.
- A Multicenter, Randomized, Double-Blind Parallel-Group, Placebo-Controlled Efficacy Study Comparing 4 Weeks of Treatment With Esomeprazole 20 mg Once Daily to Placebo qd for the Resolution of Upper Abdominal Pain in Patients With Symptomatic Gastroesophageal Reflux Disease (sGERD)CompletedNCT00626535Phase 3
- Open, Randomized, Two Way Crossover Study Comparing the Effect of Esomeprazole Adminstered Orally and ivCompletedNCT00626262Phase 4
- Study Comparing the Effects of Esomeprazole Adminstered Orally and Intravenously on Basal and Pentrigastrin-stimulated Acid Output in Subjects With Symptoms of Gastroesophageal Reflux Disease (GERD)CompletedNCT00625495Phase 4
- A Randomized, Open-Label, Comparative 3-Way Treatment Crossover Study of 24-Hour Intragastric pH Profile of Once Daily Oral Administration of Esomeprazole 40mg, Lansoprazole 30mg, and Pantoprazole 40mg at Steady State in NSAID-Using PatientsCompletedNCT00625274Phase 4
- Use Of Esomeprazole In Postoperative Bariatric Surgery Patients Users And Non-Users Of Nonsteroidal Anti-Inflammatory Drugs (NSAIDS)CompletedNCT00608712Phase 4
- vMII for Measurement of Oesophageal Bolus Transport and RefluxTerminatedNCT00604942Not applicable
- PK Study to Evaluate Esomeprazole Plasma Levels Following Administration of PN 400CompletedNCT00599404Phase 1
- Gastric pH in Critically Ill PatientsCompletedNCT00590928Phase 4
- Study to Assess Management Strategies for the Use of Esomeprazole (Nexium) in Helicobacter Pylori Infected PatientsCompletedNCT00574925Phase 4
- Effect of Acid Suppression With Esomeprazole on Vocal Cord GranulomasWithdrawnNCT00567658Phase 3
- In Vivo Quantification of Dental Demineralisation Using OCT With and Without EsomeprazoleCompletedNCT00564330Phase 1/2
- PPI-Rebound-Trial. A Study of the Clinical Relevance of the Acid Rebound PhenomenaStatus unknownNCT00526006Phase 4
- Quadruple Therapy for Triple Therapy Resistant Helicobacter Pylori InfectionCompletedNCT00520949Not applicable
- The Use of Proton Pump Inhibitor for the Treatment of Non-erosive Gastro-oesophageal Reflux Disease in Chinese PopulationStatus unknownNCT00516971Not applicable
- Phase 1 Pharmacokinetics of Intravenous Nexium in ChildrenCompletedNCT00474019Phase 1
- Preoperative Non-steroidal Anti-inflammatory Drugs(NSAID) to Colorectal Cancer PatientsCompletedNCT00473980Phase 4
- Esomeprazole and Gastric Emptying of BeerCompletedNCT00472550Phase 4
- Compare Efficacy of Gastric Acid Suppression by Oral and Intravenous Administration of Esomeprazole in Patients With Peptic UlcerStatus unknownNCT00471029Phase 4
- Esomeprazole, Moxifloxacin and Amoxicilin for Rescue Therapy of Helicobacter Pylori InfectionStatus unknownNCT00455806Phase 3
- Esomeprazole Treatment for Patients With Lymphocytic GastritisStatus unknownNCT00455754Phase 3
- Effect of Acid Reflux on Respiratory Physiology During Exercise in Athletes With GER-Response to Acid SuppressionTerminatedNCT00444236Phase 1
- Total Antioxidant Effects of Esomeprazole in Dyspeptic Patients Receiving Non-steroidal Anti-inflammatory DrugsWithdrawnNCT00443963Phase 4
- An Open-label, Exploratory Trial to Assess Gastric Acid Control in Critically Ill Subjects Receiving NexiumCompletedNCT00428701Phase 4
- Evaluation of 24-Hour Intragastric pH Using Esomeprazole, Lansoprazole, and Pantoprazole in Hispanic Patients With GERDCompletedNCT00410592Phase 4
- A Study To Investigate The Effectiveness Of AH234844 (Lavoltidine) Compared With NEXIUM And Ranitidine.CompletedNCT00405119Phase 2
- Efficacy and Safety Study of Esomeprazole vs Omeprazole to Treat Acute Non-Variceal Upper Gastrointestinal BleedingCompletedNCT00402259Phase 3
- Examine National Characteristics & Outcome Measures of GERD Patients Using the PPI Acid Suppression Symptom (PASS) Test for ResponseCompletedNCT00392002Phase 4
- PPI Sequencing StudyCompletedNCT00384592Phase 4
- Preventing Recurrent Ulcer Bleeding in Arthritis Patients Using Esomeprazole Plus CelecoxibCompletedNCT00365313Phase 3
- Study of Long-Term Use of Proton-Pump-Inhibitors in General PracticeStatus unknownNCT00363701Phase 4
- Study of Proton Pump Inhibitors (PPI) to Prevent Strictures After Gastric Bypass SurgeryWithdrawnNCT00361985Phase 4
- An Open Label pH Comparison of Esomeprazole and Lansoprazole in Barrett's Esophagus PatientsCompletedNCT00352261Phase 4
- Symptom Adapted Therapy in GERD PatientsCompletedNCT00343161Phase 4
- Nexium RESPONSE TrialCompletedNCT00318968Phase 4
- PPI Test in GP PatientsCompletedNCT00318084Phase 4
- Validation of RDQ QuestionnaireCompletedNCT00291746Phase 4
- Esomeprazole in PPI Failures - IMPROVECompletedNCT00272701Phase 4
- Nexium Dyspepsia/ASTCompletedNCT00251992Phase 3
- ASTERIX: Low Dose ASA and NexiumCompletedNCT00251966Phase 3
- Nexium Dyspepsia/ASTCompletedNCT00251914Phase 3
- Chest Pain Pilot StudyCompletedNCT00251901Phase 3
- HEARD (Long Term) Study - Histology of the Esophagus in Acid-Related DiseaseCompletedNCT00243724Phase 3
- An Open-Label Study of Once-Daily Oral Administration of Esomeprazole 40 mg in Patients With Symptoms of Gastroesophageal Reflux Disease (GERD)CompletedNCT00242736Phase 4
- Esomeprazole for Prevention of Upper Gastrointestinal Symptoms Associated With Continuous Use of NSAIDsCompletedNCT00241553Phase 3
- Esomeprazole for Relief of Upper Gastrointestinal Symptoms Associated With Continuous Use of NSAIDsCompletedNCT00241540Phase 3
- Esomeprazole for Relief of Upper Gastrointestinal Symptoms Associated With Continuous Use of NSAIDsCompletedNCT00241527Phase 3
- Esomeprazole for Prevention of Upper Gastrointestinal Symptoms Associated With Continuous Use of NSAIDsCompletedNCT00241514Phase 3
- Safety of Daily Dose Esomeprazole for GERD for Pediatric and Adolescent PatientsCompletedNCT00241501Phase 3
- Esomeprazole for Treatment of GERD in Pediatric PatientsCompletedNCT00228527Phase 4
- The Effects of Nexium on the Side Effects Associated With a Colonoscopy PrepCompletedNCT00225238Phase 4
- Evaluation of Esomeprazole in Treating Gastro-esophageal Reflux Disease (GERD) in Head and Neck Cancer Patients Exposed to Radiation TherapyTerminatedNCT00222079Not applicable
- The Effect of Nexium on Transmucosal Esophageal LeakStatus unknownNCT00216788Phase 1
- NEXIUM® in the Treatment of Moderate and Severe Erosive EsophagitisCompletedNCT00206180Phase 4
- Study of Intragastric pH Profile After 5 Days Pantoprazole 40 mg iv Followed by Oral Esomeprazole 40 mg po or Oral Pantoprazole 40 mg poCompletedNCT00206050Phase 4
- Acid-Associated Heartburn Symptoms and Dose of EsomeprazoleCompletedNCT00206024Phase 4
- Symptomatic Gastroesophageal Reflux Disease: Double Blind Randomized Controlled Study of On-demand Therapy Versus Maintenance TherapyCompletedNCT00164840Phase 3
- A Comparison of Gastric pH Control With High Dose Intravenous or Oral EsomeprazoleTerminatedNCT00164788Phase 2
- Comparison of Esomeprazole to Aerosolized, Swallowed Fluticasone for Eosinophilic EsophagitisCompletedNCT00123656Phase 2
- Proton Pump Inhibitor Treatment StopCompletedNCT00120315Phase 4
- Esomeprazole In Patients With Gastric Acid Hypersecretory States Including Idiopathic Hypersecretion and Zollinger-Ellison SyndromeCompletedNCT00079833Phase 3